Journal: The Journal of Biological Chemistry

Article Title: Inhibition of Oncogenic Epidermal Growth Factor Receptor Kinase Triggers Release of Exosome-like Extracellular Vesicles and Impacts Their Phosphoprotein and DNA Content *

doi: 10.1074/jbc.M115.679217

Figure Lengend Snippet: Responses of EGFR-driven cancer cells to EGFR inhibitors. A–C, A431 cells harboring genomic amplification of the EGFR gene were grown in monolayer cultures and exposed for 24 h to the indicated irreversible EGFR kinase inhibitors (EKIs: CI-1033 and PF-00299804) or neutralizing anti-EGFR antibody (Cetuximab) at increasing concentrations. The cells were tested for metabolic activity using the MTS assay. EKIs, but not Cetuximab, triggered marked and dose-dependent reduction in metabolic activity. D, effects of drug treatment on EGFR phosphorylation (P-EGFR; Western blotting); numerical values represent mean ± S.D. of several independent experiments; *, p > 0.05.

Article Snippet: The clonal A431-CD63/GFP cell line was prepared by transfecting A431 parental cells with the plasmid pCMV6-AC-GFP (OriGene, Rockville, MD), clone RG 201733, encoding the CD63-GFP fusion protein.

Techniques: Amplification, Activity Assay, MTS Assay, Western Blot

Journal: The Journal of Biological Chemistry

Article Title: Inhibition of Oncogenic Epidermal Growth Factor Receptor Kinase Triggers Release of Exosome-like Extracellular Vesicles and Impacts Their Phosphoprotein and DNA Content *

doi: 10.1074/jbc.M115.679217

Figure Lengend Snippet: Marked increase in the EV-mediated EGFR emission from EKI-treated cancer cells. A, unchanged levels of EGFR protein in lysates of A431 cells cultured for 24 h in the presence of control medium (control), CI-1033 (5 μm), PF-00299804 (5 μm), or Cetuximab (Cetux., 50 μg/ml), as measured by ELISA. B, unchanged levels of EGFR protein in lysates of A431 cells cultured in the presence of CI-1033 (5 μm), TGFα (50 ng/ml), or both (EGFR ELISA). C, dramatic increase in EGFR signal in the EV (P4) fraction of the conditioned medium corresponding to CI-1033 and PF-00299804 treatment; pooled data were from two independent experiments. D, increase in EV-mediated emission of EGFR upon treatment with CI-1033 and TGFα/CI-1033. The combined treatment highlights the ability of EGFR kinase inhibitor to trigger EV release; p values were as indicated. The results were independently reproduced using an antibody array (data not shown). NS, not significant.

Article Snippet: The clonal A431-CD63/GFP cell line was prepared by transfecting A431 parental cells with the plasmid pCMV6-AC-GFP (OriGene, Rockville, MD), clone RG 201733, encoding the CD63-GFP fusion protein.

Techniques: Cell Culture, Enzyme-linked Immunosorbent Assay, Ab Array

Journal: The Journal of Biological Chemistry

Article Title: Inhibition of Oncogenic Epidermal Growth Factor Receptor Kinase Triggers Release of Exosome-like Extracellular Vesicles and Impacts Their Phosphoprotein and DNA Content *

doi: 10.1074/jbc.M115.679217

Figure Lengend Snippet: Differential EGFR phosphorylation profiles of cancer cells and their EVs in the presence or absence of PF-00299804 treatment. A431 cells and corresponding EV preparations were subjected to Western blotting for EGFR and for three different EGFR phosphosites (Tyr-845, Tyr-1068, and Tyr-1173). EVs differ in their EGFR phosphorylation profiles from their parental cells, including preponderance of 2 out of 3 phosphoisoforms of EGFR following drug treatment.

Article Snippet: The clonal A431-CD63/GFP cell line was prepared by transfecting A431 parental cells with the plasmid pCMV6-AC-GFP (OriGene, Rockville, MD), clone RG 201733, encoding the CD63-GFP fusion protein.

Techniques: Western Blot

Journal: The Journal of Biological Chemistry

Article Title: Inhibition of Oncogenic Epidermal Growth Factor Receptor Kinase Triggers Release of Exosome-like Extracellular Vesicles and Impacts Their Phosphoprotein and DNA Content *

doi: 10.1074/jbc.M115.679217

Figure Lengend Snippet: Differential phosphorylation profiles of EGFR, AKT, and ERK in cancer cells and their EVs following treatment with pan-Erb kinase inhibitor CI-1033. A431 cells were treated with the EGFR agonist (TGFα, 50 ng/ml), irreversible ErbB kinase inhibitor (CI-1033, 5 μm), or both. The cells and EVs were collected 24 h later and immunoblotted for total EGFR, three different EGFR phosphosites (P-EGFR Tyr-845, Tyr-1068, and Tyr-1173), AKT, P-AKT (Ser-473), ERK, and P-ERK (Thr-202/Tyr-Y204). As loading controls, β-actin and Ponceau red were used for cell and EV lysates, respectively. EVs differ in their EGFR phosphorylation profile from their parental cells. P-EGFR is less abundant in EVs than in corresponding cells. EVs accumulate Tyr-845 and Tyr-1068 P-EGFR isoforms, but not Tyr-1173, following treatment with CI-1033. EV-associated Tyr-1173 is increased following stimulation with TGFα. EVs contain no detectable P-AKT but are enriched for ERK and P-ERK following CI-1033 treatment (see text for details).

Article Snippet: The clonal A431-CD63/GFP cell line was prepared by transfecting A431 parental cells with the plasmid pCMV6-AC-GFP (OriGene, Rockville, MD), clone RG 201733, encoding the CD63-GFP fusion protein.

Techniques:

Journal: The Journal of Biological Chemistry

Article Title: Inhibition of Oncogenic Epidermal Growth Factor Receptor Kinase Triggers Release of Exosome-like Extracellular Vesicles and Impacts Their Phosphoprotein and DNA Content *

doi: 10.1074/jbc.M115.679217

Figure Lengend Snippet: Pharmacological blockade of the oncogenic EGFR triggers emission of EVs with exosomal characteristics. A431-CD63/GFP cells were cultured for 24 h in the presence of control media or EGFR blocking concentrations of CI-1033 (5 μm). A, EVs were collected by ultracentrifugation at either 2500 × g (EV-P2) or 110,000 × g (EV-P4) and immunoblotted for EGFR or GFP, the latter to reveal the exogenous GFP/CD63 chimeric protein marker of exosomes. P4 fraction containing exosome-sized EVs was enriched in EGFR and GFP, especially after the CI-1033 treatment. B and C, A431-derived EVs were floated on the sucrose gradient, and the respective fractions were profiled for size and numerical EV distribution using nanoparticle tracking analysis system (NTA, Nanosight). Of note is the fact that CI-1033 treatment stimulated production of mainly small EVs (exosome-like), with sizes ranging between 51 and 150 nm and density between 1.11 and 1.21 g/ml, which corresponded to sucrose density fractions 3–8. NTA of individual fractions containing cancer cell-derived EVs suggests a highly heterogeneous size distribution. D and E, exosomal fractions (1.12–1.17 g/ml) of EVs purified from conditioned medium of control A431-CD63/GFP cells contain both EGFR and GFP (CD63) markers (immunoblotting). CI-1033 treatment triggered the increase in the EGFR and exosomal marker content (GFP-CD63 and CD9) across exosomal fractions 1.10–1.21 g/ml of A431-GFP/CD63-derived EVs. Data are representative of three independent experiments (see text for details).

Article Snippet: The clonal A431-CD63/GFP cell line was prepared by transfecting A431 parental cells with the plasmid pCMV6-AC-GFP (OriGene, Rockville, MD), clone RG 201733, encoding the CD63-GFP fusion protein.

Techniques: Cell Culture, Blocking Assay, Marker, Derivative Assay, Purification, Western Blot

Journal: The Journal of Biological Chemistry

Article Title: Inhibition of Oncogenic Epidermal Growth Factor Receptor Kinase Triggers Release of Exosome-like Extracellular Vesicles and Impacts Their Phosphoprotein and DNA Content *

doi: 10.1074/jbc.M115.679217

Figure Lengend Snippet: EKI-induced cellular vesiculation depends on the neutral sphingomyelinase pathway of exosomal biogenesis. A, NTA analysis of EVs emitted from A431 cells treated with EKI (CI-1033 (CI)), inhibitor of neutral sphingomyelinase (GW4869), inhibitor of acidic sphingomyelinase (FTY720), or their indicated combinations. Of note is a shift to the right in the median size peak of EVs in presence of GW4869 indicative of reduced numbers of exosome-seized vesicles and the preponderance of larger EV sizes. B, EV output into the A431 conditioned medium as measured within the median exosome size (range 150–200 nm) of vesicles. CI-1033-induced increase in EV numbers is attenuated by GW4869 pretreatment but not by FTY720 pretreatment, which increases the EV production; compilation is of three independent experiments, and p value is as indicated. NS, nonsignificant.

Article Snippet: The clonal A431-CD63/GFP cell line was prepared by transfecting A431 parental cells with the plasmid pCMV6-AC-GFP (OriGene, Rockville, MD), clone RG 201733, encoding the CD63-GFP fusion protein.

Techniques:

Journal: The Journal of Biological Chemistry

Article Title: Inhibition of Oncogenic Epidermal Growth Factor Receptor Kinase Triggers Release of Exosome-like Extracellular Vesicles and Impacts Their Phosphoprotein and DNA Content *

doi: 10.1074/jbc.M115.679217

Figure Lengend Snippet: EKI-triggered vesiculation involves caspase activity. A, activation of caspase 3 in A431 cells treated with CI-1033 and etoposide. Floating (P1) cells reveal the cleaved caspase 3 (lower) band. Cell cultures were treated with growth inhibitory (5 μm) and subthreshold (1 μm) concentrations of CI-1033, and with pro-apoptotic concentrations of etoposide. In all cases caspase 3 cleavage was inhibited by ZVAD peptide. No cleaved caspase was detectable in adherent cells. Caspase 3 was undetectable in microvesicle-like (P2) and exosome-like (P4) EV fractions. B–E, NTA profile reveals that growth inhibitory dosing of CI-1033 (5 μm), but not of etoposide, evoked vesicular emissions from A431 cells, despite caspase 3 activation in both cases. CI-1033-induced EV release was selectively inhibited by ZVAD pretreatment, as demonstrated by NTA of total (C), and exosome-like (150–200 nm (D)) vesicle populations, but this effect was not observed in larger microvesicle-like EV subsets (350–400 nm; E); data are representative of three independent experiments, p value is as indicated. NS, nonsignificant.

Article Snippet: The clonal A431-CD63/GFP cell line was prepared by transfecting A431 parental cells with the plasmid pCMV6-AC-GFP (OriGene, Rockville, MD), clone RG 201733, encoding the CD63-GFP fusion protein.

Techniques: Activity Assay, Activation Assay

Journal: The Journal of Biological Chemistry

Article Title: Inhibition of Oncogenic Epidermal Growth Factor Receptor Kinase Triggers Release of Exosome-like Extracellular Vesicles and Impacts Their Phosphoprotein and DNA Content *

doi: 10.1074/jbc.M115.679217

Figure Lengend Snippet: EKI treatment leads to cellular emission of genomic DNA within exosome-like fraction of EVs. A, A431 cells were cultured and treated with CI-1033 (5 μm), and sucrose fractions of their EVs were tested for extracellular genomic DNA using QC Analyzer (A) or PCR (B) assays. EV fractions are as follows: 3 (below exosomal density), 6 (exosomal like), and 9 (above exosomal density) were analyzed for DNA content. DNA was detected (arrowhead) only in fractions 6 and 9, and upon treatment with CI-1033. B, PCR amplification of the EGFR (exon 18) genomic sequence in A431-derived EV fractions obtained with and without CI-1033 treatment. These profiles suggest the emission of DNA within exosome-like fractions of EVs following the EGFR blockade. EVs at a higher density contain gDNA regardless of treatment (see text for details).

Article Snippet: The clonal A431-CD63/GFP cell line was prepared by transfecting A431 parental cells with the plasmid pCMV6-AC-GFP (OriGene, Rockville, MD), clone RG 201733, encoding the CD63-GFP fusion protein.

Techniques: Cell Culture, Amplification, Sequencing, Derivative Assay

Journal: The Journal of Biological Chemistry

Article Title: Inhibition of Oncogenic Epidermal Growth Factor Receptor Kinase Triggers Release of Exosome-like Extracellular Vesicles and Impacts Their Phosphoprotein and DNA Content *

doi: 10.1074/jbc.M115.679217

Figure Lengend Snippet: EV-mediated extracellular co-emission of EGFR and DNA following cancer cell exposure to EKIs. A, experimental design: ImmunoCapture of pre-filtered, EGFR-containing EVs produced by A431 cells either in the absence of in the presence of EKIs, followed by detection of extracellular genomic DNA (exo-gDNA; PCR). B, analysis of EGFR genomic sequences in EV fractions captured on plates coated with anti-EGFR antibody. This assay reveals that the same population of small EGFR-positive exosome-like EVs, which are able to pass through both 0.8- and 0.45-μm filters, is enriched in exo-gDNA, but only if the cells were pretreated with growth inhibitory doses of EKIs, CI-1033 or PF-00299804 (see text for details). UC, ultracentrifugation; -, possible but not obligatory step in the procedure.

Article Snippet: The clonal A431-CD63/GFP cell line was prepared by transfecting A431 parental cells with the plasmid pCMV6-AC-GFP (OriGene, Rockville, MD), clone RG 201733, encoding the CD63-GFP fusion protein.

Techniques: Produced, Genomic Sequencing

Journal: Bioengineered

Article Title: KLF9 (Kruppel Like Factor 9) induced PFKFB3 (6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3) downregulation inhibits the proliferation, metastasis and aerobic glycolysis of cutaneous squamous cell carcinoma cells

doi: 10.1080/21655979.2021.1980644

Figure Lengend Snippet: PFKFB3 is highly expressed in CSCC cells. (a) PFKFB3 mRNA expression and (b) PFKFB3 expression in CSCC cells and HaCaT cells was respectively examined using RT-qPCR and Western blot. ***P < 0.001 vs. HaCaT

Article Snippet: Human immortalized keratinocytes (HaCaT) and human CSCC cells (SCL-1, SCC13, HSC-5 and A431) were purchased from BioVector NTCC Inc. (Beijing, China).

Techniques: Expressing, Quantitative RT-PCR, Western Blot

Journal: Bioengineered

Article Title: KLF9 (Kruppel Like Factor 9) induced PFKFB3 (6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3) downregulation inhibits the proliferation, metastasis and aerobic glycolysis of cutaneous squamous cell carcinoma cells

doi: 10.1080/21655979.2021.1980644

Figure Lengend Snippet: PFKFB3 silencing suppresses the proliferation of CSCC cells. (a) PFKFB3 mRNA expression and (b) PFKFB3 protein expression in A431 cells after transfection with shRNA-PFKFB3#1/2 was respectively tested by RT-qPCR and Western blot. (c) The viability, (d) proliferation and (e) Ki-67 expression of A431 cells transfected with shRNA-PFKFB3#2 was in turn analyzed by MTT assay, clone formation assay and immunofluorescence assay. *P < 0.05 and ***P < 0.001 vs. Control. ## P < 0.01 and ### P < 0.001 vs. shRNA-NC. @@ P < 0.01 vs. shRNA-PFKFB3#1

Article Snippet: Human immortalized keratinocytes (HaCaT) and human CSCC cells (SCL-1, SCC13, HSC-5 and A431) were purchased from BioVector NTCC Inc. (Beijing, China).

Techniques: Expressing, Transfection, shRNA, Quantitative RT-PCR, Western Blot, MTT Assay, Tube Formation Assay, Immunofluorescence

Journal: Bioengineered

Article Title: KLF9 (Kruppel Like Factor 9) induced PFKFB3 (6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3) downregulation inhibits the proliferation, metastasis and aerobic glycolysis of cutaneous squamous cell carcinoma cells

doi: 10.1080/21655979.2021.1980644

Figure Lengend Snippet: PFKFB3 knockdown restrains the metastasis of CSCC cells. (a) The migration and (b) invasion of A431 cells transfected with shRNA-PFKFB3#2 were respectively evaluated with wound healing assay and transwell assay. The levels of (c) migration and invasion related proteins and (d) EMT related proteins in A431 cells transfected with shRNA-PFKFB3#2 were assessed using Western blot. ***P < 0.001 vs. Control. ### P < 0.001 vs. shRNA-NC

Article Snippet: Human immortalized keratinocytes (HaCaT) and human CSCC cells (SCL-1, SCC13, HSC-5 and A431) were purchased from BioVector NTCC Inc. (Beijing, China).

Techniques: Migration, Transfection, shRNA, Wound Healing Assay, Transwell Assay, Western Blot

Journal: Bioengineered

Article Title: KLF9 (Kruppel Like Factor 9) induced PFKFB3 (6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3) downregulation inhibits the proliferation, metastasis and aerobic glycolysis of cutaneous squamous cell carcinoma cells

doi: 10.1080/21655979.2021.1980644

Figure Lengend Snippet: PFKFB3 knockdown inhibits the aerobic glycolysis of CSCC cells. (a) The glucose consumption, (b) lactic acid production and (c) ATP production in A431 cells transfected with shRNA-PFKFB3#2 were in turn detected by Glucose Assay kit, L-Lactic Acid Colorimetric Assay kit and ATP Assay Kit. (d) The levels of aerobic glycolysis related proteins in A431 cells transfected with shRNA-PFKFB3#2 was analyzed by Western blot. ***P < 0.001 vs. Control. ### P < 0.001 vs. shRNA-NC

Article Snippet: Human immortalized keratinocytes (HaCaT) and human CSCC cells (SCL-1, SCC13, HSC-5 and A431) were purchased from BioVector NTCC Inc. (Beijing, China).

Techniques: Transfection, shRNA, Glucose Assay, Colorimetric Assay, ATP Assay, Western Blot

Journal: Bioengineered

Article Title: KLF9 (Kruppel Like Factor 9) induced PFKFB3 (6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3) downregulation inhibits the proliferation, metastasis and aerobic glycolysis of cutaneous squamous cell carcinoma cells

doi: 10.1080/21655979.2021.1980644

Figure Lengend Snippet: KLF9 negatively modulated PFKFB3 transcription in CSCC. (a) The binding sites between KLF9 and PFKFB3. (b) KLF9 mRNA expression and (c) KLF9 protein expression in several CSCC cells and HaCaT cells was respectively determined with RT-qPCR and Western blot. **P < 0.01 and ***P < 0.001 vs. HaCaT. (d) KLF9 mRNA expression and (e) KLF9 protein expression in A431 cells after transfection was measured with RT-qPCR and Western blot. ***P < 0.001 vs. Control. ### P < 0.001 vs. shRNA-NC. @@@ P < 0.001 vs. shRNA-KLF9#1. $$$ P < 0.001 vs. pcDNA3.1. (f)The interaction between KLF9 and PFKFB3 was analyzed by dual-luciferase reporter assay. ***P < 0.001 vs. pcDNA3.1. (g) The binding ability of KLF9 to PFKFB3 promoter was evaluated with ChIP. ***P < 0.001 vs. IgG

Article Snippet: Human immortalized keratinocytes (HaCaT) and human CSCC cells (SCL-1, SCC13, HSC-5 and A431) were purchased from BioVector NTCC Inc. (Beijing, China).

Techniques: Binding Assay, Expressing, Quantitative RT-PCR, Western Blot, Transfection, shRNA, Luciferase, Reporter Assay

Journal: Bioengineered

Article Title: KLF9 (Kruppel Like Factor 9) induced PFKFB3 (6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3) downregulation inhibits the proliferation, metastasis and aerobic glycolysis of cutaneous squamous cell carcinoma cells

doi: 10.1080/21655979.2021.1980644

Figure Lengend Snippet: KLF9 knockdown attenuated the impacts of PFKFB3 knockdown on the proliferation of CSCC cells. (a) PFKFB3 mRNA expression and (b) PFKFB3 protein expression in A431 cells transfected with shRNA-PFKFB3#2 and shRNA-KLF9#2 was respectively detected using RT-qPCR and Western blot. (c) The viability, (d) proliferation and (e) Ki-67 expression of A431 cells transfected with shRNA-PFKFB3#2 and shRNA-KLF9#2 was tested with MTT assay, clone formation assay and immunofluorescence analysis. *P < 0.05 and ***P < 0.001 vs. Control. # P < 0.05 and ### P < 0.001 vs. shRNA-NC. @ P < 0.05 and @@@ P < 0.001 vs. shRNA-PFKFB3. $ P < 0.05 and $$$ P < 0.001 vs. shRNA-PFKFB3 + shRNA-NC

Article Snippet: Human immortalized keratinocytes (HaCaT) and human CSCC cells (SCL-1, SCC13, HSC-5 and A431) were purchased from BioVector NTCC Inc. (Beijing, China).

Techniques: Expressing, Transfection, shRNA, Quantitative RT-PCR, Western Blot, MTT Assay, Tube Formation Assay, Immunofluorescence

Journal: Bioengineered

Article Title: KLF9 (Kruppel Like Factor 9) induced PFKFB3 (6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3) downregulation inhibits the proliferation, metastasis and aerobic glycolysis of cutaneous squamous cell carcinoma cells

doi: 10.1080/21655979.2021.1980644

Figure Lengend Snippet: KLF9 knockdown reversed the inhibitory effect of PFKFB3 knockdown on the metastasis of CSCC cells. (a) The migration and (b) invasion of A431 cells transfected with shRNA-PFKFB3#2 and shRNA-KLF9#2 were assessed with wound healing assay and transwell assays. The expression of (c) migration and invasion related proteins and (d) EMT related proteins in A431 cells transfected with shRNA-PFKFB3#2 and shRNA-KLF9#2 was examined by Western blot. ***P < 0.001 vs. Control. ### P < 0.001 vs. shRNA-NC. @ P < 0.05, @@ P < 0.01 and @@@ P < 0.001 vs. shRNA-PFKFB3. $ P < 0.05, $$ P < 0.01 and $$$ P < 0.001 vs. shRNA-PFKFB3 + shRNA-NC

Article Snippet: Human immortalized keratinocytes (HaCaT) and human CSCC cells (SCL-1, SCC13, HSC-5 and A431) were purchased from BioVector NTCC Inc. (Beijing, China).

Techniques: Migration, Transfection, shRNA, Wound Healing Assay, Expressing, Western Blot

Journal: Bioengineered

Article Title: KLF9 (Kruppel Like Factor 9) induced PFKFB3 (6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3) downregulation inhibits the proliferation, metastasis and aerobic glycolysis of cutaneous squamous cell carcinoma cells

doi: 10.1080/21655979.2021.1980644

Figure Lengend Snippet: KLF9 silencing reversed the inhibitory effect of PFKFB3 knockdown on the aerobic glycolysis of CSCC cells. (a) The glucose consumption, (b) lactic acid production and (c) ATP production in A431 cells transfected with shRNA-PFKFB3#2 and shRNA-KLF9#2 were examined using Glucose Assay kit, L-Lactic Acid Colorimetric Assay kit and ATP Assay Kit. (d) The levels of aerobic glycolysis related proteins in A431 cells transfected with shRNA-PFKFB3#2 and shRNA-KLF9#2 was tested with Western blot. ***P < 0.001 vs. Control. ### P < 0.001 vs. shRNA-NC. @@@ P < 0.001 vs. shRNA-PFKFB3. $$$ P < 0.001 vs. shRNA-PFKFB3 + shRNA-NC

Article Snippet: Human immortalized keratinocytes (HaCaT) and human CSCC cells (SCL-1, SCC13, HSC-5 and A431) were purchased from BioVector NTCC Inc. (Beijing, China).

Techniques: Transfection, shRNA, Glucose Assay, Colorimetric Assay, ATP Assay, Western Blot

Journal: BMC Cancer

Article Title: Aberrant methylation of the M-type phospholipase A 2 receptor gene in leukemic cells

doi: 10.1186/1471-2407-12-576

Figure Lengend Snippet: PLA2R1 gene methylations in different human cell lines

Article Snippet: In addition, genomic DNA from Raji (human B-cell leukemia), MCF7 (human mammary adenocarcinoma), and A431 (human melanoma) cell lines was purchased from BioCat GmbH (Heidelberg, Germany).

Techniques: Methylation

Journal: Engineering in Life Sciences

Article Title: Low‐frequency mechanical vibration induces apoptosis of A431 epidermoid carcinoma cells

doi: 10.1002/elsc.201900154

Figure Lengend Snippet: Mechanical vibration induces apoptosis but not necrosis of A431 cells. (A, C, and E) Area of apoptotic A431 cells (A A ) normalized to the value for control cells immediately after mechanical vibration (0 h, A) or after 24‐h (B) and 48‐h (C) incubation. (B, D, and F) As described for (A), (C), and (E), except the area of necrotic cells normalized to the control cells (A N ) is shown. Data are presented as the mean ± SD of n = 3. * P < 0.05 by Student's t ‐test

Article Snippet: The human epidermoid carcinoma cell line A431, which is considered a good model to study the biomechanical response of cancer cells to extracellular stimuli , was obtained from RIKEN (Wako, Saitama, Japan).

Techniques: Incubation

Journal: Engineering in Life Sciences

Article Title: Low‐frequency mechanical vibration induces apoptosis of A431 epidermoid carcinoma cells

doi: 10.1002/elsc.201900154

Figure Lengend Snippet: Mechanical vibration increases glucose consumption by A431 cells. Glucose uptake in culture supernatants was measured between 0 h and 24 h (A) or between 24 h and 48 h (B) after mechanical vibration. Data are presented as the mean ± SD of n = 3

Article Snippet: The human epidermoid carcinoma cell line A431, which is considered a good model to study the biomechanical response of cancer cells to extracellular stimuli , was obtained from RIKEN (Wako, Saitama, Japan).

Techniques:

Journal: Engineering in Life Sciences

Article Title: Low‐frequency mechanical vibration induces apoptosis of A431 epidermoid carcinoma cells

doi: 10.1002/elsc.201900154

Figure Lengend Snippet: Mechanical vibration does not increase HMGB1 release from A431 cells. HMGB1 levels in culture supernatants were analyzed by ELISA immediately after 0 h (A), or 24 h (B) and 48 h (C) after vibration. Data are presented as the mean ± SD of n = 3

Article Snippet: The human epidermoid carcinoma cell line A431, which is considered a good model to study the biomechanical response of cancer cells to extracellular stimuli , was obtained from RIKEN (Wako, Saitama, Japan).

Techniques: Enzyme-linked Immunosorbent Assay